Report cover image

Insulin Pens Market - Global Outlook & Forecast 2022-2027

Publisher Arizton Advisory and Intelligence
Published Mar 24, 2022
Length 260 Pages
SKU # ARZ17043164

Description

Insulin Pens Market - Global Outlook & Forecast 2022-2027

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Insulin Pens Market Report

There will be an increase in demand for Insulin Pens in the forecast period due to its long-term cost-effectiveness and other advantages such as accuracy, better convenience, and ease of use over conventional insulin pens. Other than high-income countries with full diabetes insurance coverage, several middle-income countries have started adopting it with advanced technologies. In some countries in Europe, for example, France, Spain, and Germany, doctors highly prescribe insulin pens under the health insurance coverage with a reasonable cutting cost, which makes it more cost-effective than insulin syringes.

The insulin pens market is expected to grow at a CAGR of 6.26% during the forecast period

GLOBAL INSULIN PENS MARKET SEGMENTATION
  • The traditional insulin pens dominated the market. However, smart insulin pens are expected to increase significantly in the forecast period across the globe.
  • Hospitals & Clinics dominated the distribution channel segment because of the easy access to insulin pens in the hospital pharmacies and thus doctors are increasingly prescribing insulin pens in both high- and low-income countries.
Segmentation by Product
  • Traditional
  • Smart
Segmentation by Usage
  • Disposable
  • Reusable
Segmentation by Distribution Channel
  • Hospitals & Clinics
  • Standalone Pharmacies
  • Online
GEOGRAPHICAL OUTLOOK
  • Europe dominated the market due to high prevalence of diabetes in the region. APAC region is expected to grow at faster rate in the forecast period with the CAGR of 7.26% because of the increase in awareness and the target population.
Segmentation by Geography
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • North America
  • US
  • Canada
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Turkey
  • South Africa
  • Saudi Arabia
  • UAE
VENDOR LANDSCAPE
  • The leading vendors in the insulin pen industry are Lilly, Medtronic, Novo Nordisk, and Sanofi. The market competition is solely based on quality, quantity, technology, safety, and price.
KEY VENDORS
  • Lilly
  • Medtronic
  • Novo Nordisk
  • Sanofi
    • OTHER PROMINENT VENDORS
    • BD
    • Biocon
    • Diamesco
    • Emperra
    • Guangzhou Medsinglong Medical Equipment
    • HK Zion Industry
    • Jiangsu Delfu Medical Device
    • Owen Mumford
    • Shanghai Umitai Medical Technology
    • Sun Medical Products
    • Suzhou Peng Ye Medical Technology Co., Ltd.
    • Triones Technology (Guangzhou)
    • Ypsomed
    THE REPORT INCLUDES:

    1. The analysis of the global Insulin Pens market provides market size and growth rate for the forecast period 2022-2027.

    2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Insulin Pens market.

    3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.

    4. It offers a complete overview of market segments and the regional outlook of the global Insulin Pens market.

    5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.

    Table of Contents

    260 Pages
    1 RESEARCH METHODOLOGY
    2 RESEARCH OBJECTIVES
    3 RESEARCH PROCESS
    4 SCOPE & COVERAGE
    4.1 MARKET DEFINITION
    4.1.1 INCLUSIONS
    4.1.2 EXCLUSIONS
    4.1.3 MARKET ESTIMATION CAVEATS
    4.2 BASE YEAR
    4.3 SCOPE OF THE STUDY
    4.3.1 MARKET SEGMENTATION BY PRODUCT
    4.3.2 MARKET SEGMENTATION BY USAGE
    4.3.3 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
    4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
    5 REPORT ASSUMPTIONS & CAVEATS
    5.1 KEY CAVEATS
    5.2 CURRENCY CONVERSION
    5.3 MARKET DERIVATION
    6 MARKET AT A GLANCE
    7 INTRODUCTION
    7.1 OVERVIEW
    8 MARKET OPPORTUNITIES & TRENDS
    8.1 TECHNOLOGICAL ADVANCEMENTS IN INSULIN PENS
    8.2 INCREASED DEMAND FOR SMART INSULIN PENS
    8.3 INTRODUCTION OF INTEGRATED SMART PEN SYSTEMS
    9 MARKET GROWTH ENABLERS
    9.1 RISING PREVALENCE OF DIABETES
    9.2 INCREASED USE OF INSULIN PENS IN AMBULATORY SETTINGS
    9.3 GROWTH IN PRODUCT LAUNCHES
    10 MARKET GROWTH RESTRAINTS
    10.1 COMPLICATIONS ASSOCIATED WITH INSULIN PENS
    10.2 HIGH COST & LACK OF UNIVERSAL INSURANCE COVERAGE
    10.3 LARGE POPULATIONS WITH UNDIAGNOSED DIABETES
    11 MARKET LANDSCAPE
    11.1 MARKET OVERVIEW
    11.2 MARKET SIZE & FORECAST
    11.2.1 PRODUCT INSIGHTS
    11.2.2 USAGE INSIGHTS
    11.2.3 DISTRIBUTION CHANNEL INSIGHTS
    11.2.4 GEOGRAPHY INSIGHTS
    11.3 FIVE FORCES ANALYSIS
    11.3.1 THREAT OF NEW ENTRANTS
    11.3.2 BARGAINING POWER OF SUPPLIERS
    11.3.3 BARGAINING POWER OF BUYERS
    11.3.4 THREAT OF SUBSTITUTES
    11.3.5 COMPETITIVE RIVALRY
    12 PRODUCT
    12.1 MARKET SNAPSHOT & GROWTH ENGINE
    12.2 MARKET OVERVIEW
    12.3 TRADITIONAL INSULIN PENS
    12.3.1 MARKET OVERVIEW
    12.3.2 MARKET SIZE & FORECAST
    12.3.3 TRADITIONAL INSULIN PENS BY GEOGRAPHY
    12.4 SMART INSULIN PENS
    12.4.1 MARKET OVERVIEW
    12.4.2 MARKET SIZE & FORECAST
    12.4.3 SMART INSULIN PENS BY GEOGRAPHY
    13 USAGE
    13.1 MARKET SNAPSHOT & GROWTH ENGINE
    13.2 MARKET OVERVIEW
    13.3 DISPOSABLE INSULIN PENS
    13.3.1 MARKET OVERVIEW
    13.3.2 MARKET SIZE & FORECAST
    13.3.3 DISPOSABLE INSULIN PENS BY GEOGRAPHY
    13.4 REUSABLE INSULIN PENS
    13.4.1 MARKET OVERVIEW
    13.4.2 MARKET SIZE & FORECAST
    13.4.3 REUSABLE INSULIN PENS BY GEOGRAPHY
    14 DISTRIBUTION CHANNEL
    14.1 MARKET SNAPSHOT & GROWTH ENGINE
    14.2 MARKET OVERVIEW
    14.3 HOSPITALS & CLINICS
    14.3.1 MARKET OVERVIEW
    14.3.2 MARKET SIZE & FORECAST
    14.3.3 HOSPITALS & CLINICS BY GEOGRAPHY
    14.4 STANDALONE PHARMACIES
    14.4.1 MARKET OVERVIEW
    14.4.2 MARKET SIZE & FORECAST
    14.4.3 STANDALONE PHARMACIES BY GEOGRAPHY
    14.5 ONLINE
    14.5.1 MARKET OVERVIEW
    14.5.2 MARKET SIZE & FORECAST
    14.5.3 ONLINE BY GEOGRAPHY
    15 GEOGRAPHY
    15.1 GEOGRAPHIC OVERVIEW
    15.2 MARKET SNAPSHOT & GROWTH ENGINE
    16 EUROPE
    16.1 MARKET OVERVIEW
    16.2 MARKET SIZE & FORECAST
    16.3 EUROPE: MARKET BY PRODUCT
    16.4 EUROPE: MARKET BY USAGE
    16.5 EUROPE: DISTRIBUTION CHANNEL
    16.7 KEY COUNTRIES
    16.7.1 GERMANY: MARKET SIZE & FORECAST
    16.7.2 FRANCE: MARKET SIZE & FORECAST
    16.7.3 UK: MARKET SIZE & FORECAST
    16.7.4 ITALY: MARKET SIZE & FORECAST
    16.7.5 SPAIN: MARKET SIZE & FORECAST
    17 NORTH AMERICA
    17.1 MARKET OVERVIEW
    17.2 MARKET SIZE & FORECAST
    17.3 NORTH AMERICA: MARKET BY PRODUCT
    17.4 NORTH AMERICA: MARKET BY USAGE
    17.5 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL
    17.7 KEY COUNTRIES
    17.7.1 US: MARKET SIZE & FORECAST
    17.7.2 CANADA: MARKET SIZE & FORECAST
    18 APAC
    18.1 MARKET OVERVIEW
    18.2 MARKET SIZE & FORECAST
    18.3 APAC: MARKET BY PRODUCT
    18.4 APAC: MARKET BY USAGE
    18.5 APAC: MARKET BY DISTRIBUTION CHANNEL
    18.6 KEY COUNTRIES
    18.6.1 CHINA: MARKET SIZE & FORECAST
    18.6.2 JAPAN: MARKET SIZE & FORECAST
    18.6.3 INDIA: MARKET SIZE & FORECAST
    18.6.4 SOUTH KOREA: MARKET SIZE & FORECAST
    18.6.5 AUSTRALIA: MARKET SIZE & FORECAST
    19 LATIN AMERICA
    19.1 MARKET OVERVIEW
    19.2 MARKET SIZE & FORECAST
    19.3 LATIN AMERICA: MARKET BY PRODUCT
    19.4 LATIN AMERICA: MARKET BY USAGE
    19.5 LATIN: MARKET BY DISTRIBUTION CHANNEL
    19.6 KEY COUNTRIES
    19.6.1 BRAZIL: MARKET SIZE & FORECAST
    19.6.2 MEXICO: MARKET SIZE & FORECAST
    19.6.3 ARGENTINA: MARKET SIZE & FORECAST
    20 MIDDLE EAST & AFRICA
    20.1 MARKET OVERVIEW
    20.2 MARKET SIZE & FORECAST
    20.3 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
    20.4 MIDDLE EAST & AFRICA: MARKET BY USAGE
    20.5 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL
    20.6 KEY COUNTRIES
    20.6.1 TURKEY: MARKET SIZE & FORECAST
    20.6.2 SOUTH AFRICA: MARKET SIZE & FORECAST
    20.6.3 SAUDI ARABIA: MARKET SIZE & FORECAST
    20.6.4 UAE: MARKET SIZE & FORECAST
    21 COMPETITIVE LANDSCAPE
    21.1 COMPETITION OVERVIEW
    21.2 MARKET SHARE ANALYSIS
    21.2.1 LILLY
    21.2.2 MEDTRONIC
    21.2.3 NOVO NORDISK
    21.2.4 SANOFI
    22 KEY COMPANY PROFILES
    22.1 LILLY
    22.1.1 BUSINESS OVERVIEW
    22.1.2 PRODUCT OFFERINGS
    22.1.3 KEY STRATEGIES
    22.1.4 KEY STRENGTHS
    22.1.5 KEY OPPORTUNITIES
    22.2 MEDTRONIC
    22.2.1 BUSINESS OVERVIEW
    22.2.2 PRODUCT OFFERINGS
    22.2.3 KEY STRATEGIES
    22.2.4 KEY STRENGTHS
    22.2.5 KEY OPPORTUNITIES
    22.3 NOVO NORDISK
    22.3.1 BUSINESS OVERVIEW
    22.3.2 PRODUCT OFFERINGS
    22.3.3 KEY STRATEGIES
    22.3.4 KEY STRENGTHS
    22.3.5 KEY OPPORTUNITIES
    22.4 SANOFI
    22.4.1 BUSINESS OVERVIEW
    22.4.2 PRODUCT OFFERINGS
    22.4.3 KEY STRATEGIES
    22.4.4 KEY STRENGTHS
    22.4.5 KEY OPPORTUNITIES
    23 OTHER PROMINENT VENDORS
    23.1 BD
    23.1.1 BUSINESS OVERVIEW
    23.1.2 PRODUCT OFFERINGS
    23.2 BIOCON
    23.2.1 BUSINESS OVERVIEW
    23.2.2 PRODUCT OFFERINGS
    23.3 EMPERRA GMBH E-HEALTH TECHNOLOGIES
    23.3.1 BUSINESS OVERVIEW
    23.3.2 PRODUCT OFFERINGS
    23.4 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT
    23.4.1 BUSINESS OVERVIEW
    23.4.2 PRODUCT OFFERINGS
    23.5 HK ZION INDUSTRY
    23.5.1 BUSINESS OVERVIEW
    23.5.2 PRODUCT OFFERINGS
    23.6 JIANGSU DELFU MEDICAL DEVICE
    23.6.1 BUSINESS OVERVIEW
    23.6.2 PRODUCT OFFERINGS
    23.7 OWEN MUMFORD
    23.7.1 BUSINESS OVERVIEW
    23.7.2 PRODUCT OFFERINGS
    23.8 PENDIQ
    23.8.1 BUSINESS OVERVIEW
    23.8.2 PRODUCT OFFERINGS
    23.9 SHANGHAI UMITAI MEDICAL TECHNOLOGY
    23.9.1 BUSINESS OVERVIEW
    23.9.2 PRODUCT OFFERINGS
    23.10 SUN MEDICAL PRODUCTS
    23.10.1 BUSINESS OVERVIEW
    23.10.2 PRODUCT OFFERINGS
    23.11 SUZHOU PENG YE MEDICAL DEVICES
    23.11.1 BUSINESS OVERVIEW
    23.11.2 PRODUCT OFFERINGS
    23.12 TRIONES TECHNOLOGY
    23.12.1 BUSINESS OVERVIEW
    23.12.2 PRODUCT OFFERINGS
    23.13 YPSOMED
    23.13.1 BUSINESS OVERVIEW
    23.13.2 PRODUCT OFFERINGS
    24 REPORT SUMMARY
    24.1 KEY TAKEAWAYS
    24.2 STRATEGIC RECOMMENDATIONS
    25 QUANTITATIVE SUMMARY
    25.1 MARKET BY GEOGRAPHY
    25.2 MARKET BY PRODUCT
    25.3 MARKET BY USAGE
    25.4 MARKET BY DISTRIBUTION CHANNEL
    25.5 NORTH AMERICA: MARKET BY PRODUCT
    25.6 NORTH AMERICA: MARKET BY USAGE
    25.7 NORTH AMERICA: MARKET BY DISTRIBUTION CHANNEL
    25.8 APAC: MARKET BY PRODUCT
    25.9 APAC: MARKET BY USAGE
    25.10 APAC: MARKET BY DISTRIBUTION CHANNEL
    25.11 EUROPE: MARKET BY PRODUCT
    25.12 EUROPE: MARKET BY USAGE
    25.13 EUROPE: MARKET BY DISTRIBUTION CHANNEL
    25.14 LATIN AMERICA: MARKET BY PRODUCT
    25.15 LATIN AMERICA: MARKET BY USAGE
    25.16 LATIN AMERICA: MARKET BY DISTRIBUTION CHANNEL
    25.17 MIDDLE EAST & AFRICA: MARKET BY PRODUCT
    25.18 MIDDLE EAST & AFRICA: MARKET BY USAGE
    25.19 MIDDLE EAST & AFRICA: MARKET BY DISTRIBUTION CHANNEL
    26 APPENDIX
    26.1 ABBREVIATIONS

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Request A Sample
    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us